Studies examining the effect of beta2-agonists on maximal physical performance lasting longer than 1 min were included in the meta-analysis. Data are presented as standardised difference in mean (SDM) ...

To examine whether beta-agonists were associated with increased risk of sudden death in patients using the inhaled form of the agent to relieve bronchospasm, Lemaitre et al looked at 454 patients ...

However, the same meta-analysis (which combines the results of the numerous studies) found that regularly inhaled beta-agonists (metaproterenol [Alupent], formoterol [Foradil], salmeterol ...

DUBLIN--(BUSINESS WIRE)--The "Beta-3 Receptors Agonist -Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. 'Beta-3 Receptors Agonist - Pipeline Insight ...

If asthma is not controlled with low-dose inhaled corticosteroids (ICS), by far the best next step is the addition of a long-acting, inhaled beta-agonist (LABA). Questions regarding the safety of ...

However, the same meta-analysis (which combines the results of the numerous studies) found that regularly inhaled beta-agonists (metaproterenol [Alupent], formoterol [Foradil], salmeterol ...

DUBLIN--(BUSINESS WIRE)--The "Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This report ...

ORLANDO, FL — In this 6-month, first-in-human study in 70 patients with chronic heart failure, the beta 3–adrenoceptor agonist mirabegron (Myrbetriq, Astellas Pharma), which is approved to ...

Although beta-2 agonists have been associated with a reduced risk of Parkinson's disease in some previous epidemiological studies, this association was not found in a recent register-based study ...

Long-acting beta agonists (LABAs) were associated with increased risk of asthma-related death, intubation, and hospitalization in a recent meta-analysis of individual patient data conducted by the ...